KEY vs PRCT · P/E 13, rev $7.51B vs rev $224.5M
KeyCorp (KEY) versus Procept Biorobotics Corp (PRCT) — a side-by-side from cached financials, not a winner call.
KeyCorp (KEY) is a banks - regional company listed on US.
Procept Biorobotics Corp (PRCT) is a medical devices company listed on US.
Latest reported KEY revenue for 2025-12-31 was $7.51B. Net income was $1.83B. Revenue was up 62.7% from 2024-12-31 to 2025-12-31. KEY currently screens at market cap $22.64B and trailing P/E 12.8.
Latest reported PRCT revenue for 2024-12-31 was $224.5M. Net income was -$91.4M. Revenue was up 64.8% from 2023-12-31 to 2024-12-31. PRCT currently screens at market cap $1.52B.
KEY currently screens at market cap $22.64B and trailing P/E 12.8. PRCT currently screens at market cap $1.52B.
Not investment advice. Open the KEY and PRCT stock pages for the full models.
Not investment advice.